James M Daly
CIK 1560782 · EVP, Chief Commercial Officer · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.13M
Companies
7
Total Filings
74
Lifetime Open-Market Net
-$41.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACAD | Director | 12,148 | $21.09 | $256.2K | -$3.15M | 16 | 2026-06-01 |
| CYTK | Director | 3,239 | $70.15 | $227.2K | $0 | 4 | 2026-05-27 |
| MDGL | Director | 2,627 | $480.77 | $1.26M | -$13.59M | 9 | 2025-06-24 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Director | 20,503 | — | — | -$2.29M | 11 | 2023-08-15 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Director | 109,873 | $0.07 | $8.2K | $0 | 13 | 2023-01-05 |
| CHIMERIX INC (CMRX) Delisted | Director | — | $8.54 | — | $0 | 5 | 2019-06-24 |
| INCY | EVP, Chief Commercial Officer | 3,521 | $108.53 | $382.1K | -$22.72M | 16 | 2015-06-25 |
Recent Filings · Page 5 of 8
74 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-14 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-03 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | +12,173 | $0 | EDGAR |
| 2018-06-21 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-18 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-08 | ACAD | Grant (A) | — | $0 | EDGAR |
| 2018-05-02 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | +10,363 | $0 | EDGAR |
| 2017-07-19 | ACAD | Grant (A) | — | $0 | EDGAR |
| 2017-06-29 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-15 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-14 | ACAD | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.